Unverified record. The outcome below was inferred from the share-price reaction around this date. Nobody has confirmed it against an FDA, SEC or company document, and it may be wrong: we have published at least one inferred outcome that turned out to be impossible (see corrections). Treat it as a price observation, not as a regulatory fact. Verified decisions on this site always link a primary source.
Daily close, T-120 (12/25/24) through T+5. Run-up high $216.66 on 3/12/25, low $169.2 on 1/27/25 (T-120 to T-1). FDA decision 6/11/25. Historical price action, not a forecast.
Decision facts
FDA decision date2025-06-11
OutcomeUnconfirmed · price consistent with approval~ price-only (validating)
Decision-day move+1.1%
T-120 run-up (low→high)+14.0% ($170.16→$216.66)
ValidationOutcome consistent with price; primary-source verification in progress.
Market-cap tierLarge
Cohort decision-day move (history)1.0% median (n=827)
Cohort move is the historical median absolute decision-day move for this market-cap tier across our run-up study. History, not a prediction.